UnitedHealth Faces DOJ Lawsuit to Block Merger with Amedisys
Deal News | Nov 13, 2024 | EIN
The U.S. Department of Justice (DOJ) has filed a lawsuit to block the proposed merger between UnitedHealth Group and Amedisys, citing anticompetitive concerns. According to the DOJ and the attorneys general from Maryland, Illinois, New Jersey, and New York, the merger would significantly reduce competition in the home health and hospice sectors, potentially leading to UnitedHealth's control of over 30% of these services in eight states. Both companies are major competitors in this space, and the consolidation would potentially harm the market by making UnitedHealth too dominant, particularly as the population ages. The DOJ also seeks civil penalties for Amedisys's alleged failure to comply with antitrust regulations and UnitedHealth's potential breach of the Clayton Antitrust Act. Despite an alternative merger offer from OptionCare, Amedisys chose UnitedHealth's proposal. A proposed divestiture plan involving VitalCaring Group does not alleviate competitive concerns. This merger is part of UnitedHealth's broader strategy to expand its reach across the U.S. healthcare system, having spent $36 billion in acquisitions over the past three years.
Sectors
- Healthcare
- Insurance
- Legal
Geography
- United States – The article discusses companies and legal actions taking place within the United States, impacting multiple states including Maryland, Illinois, New Jersey, and New York.
Industry
- Healthcare – The article involves companies operating within the healthcare sector, specifically focusing on home health and hospice services.
- Insurance – UnitedHealth Group is a major player in the health insurance industry, and its acquisition strategy is pertinent to its role as an insurer.
- Legal – The article discusses legal issues, particularly relating to antitrust laws and regulations impacting the merger.
Financials
- 30% – Potential market control by UnitedHealth in home health or hospice services if the merger proceeds.
- $3.3 billion – The value of UnitedHealth's merger offer to Amedisys.
- $36 billion – The total amount spent by UnitedHealth in acquisitions over the past three years.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| UnitedHealth Group | Acquirer | Company | A leading insurance and healthcare provider involved in the acquisition of Amedisys. |
| Amedisys | Target | Company | A major home health and hospice provider targeted for acquisition by UnitedHealth Group. |
| Department of Justice | Plaintiff | Government | The U.S. government entity filing a lawsuit to block the merger due to antitrust concerns. |
| VitalCaring Group | Divestiture Buyer | Company | Proposed buyer for divested assets, facing its own legal challenges, hence not resolving competitive concerns. |
| OptionCare | Alternative Merger Partner | Company | An infusion provider initially set to merge with Amedisys before UnitedHealth's acquisition proposal. |
| Humana | Competitor | Company | An existing competitor that owns one of the largest home health providers, Kindred. |
| Attorneys General of Maryland, Illinois, New Jersey, and New York | Plaintiffs | Government | State legal representatives supporting the lawsuit against the merger. |